Navigation Links
Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients
Date:9/17/2008

PARIS, and TORONTO, Sept. 17 /PRNewswire/ -- Sanofi pasteur, the vaccines division of the sanofi-aventis Group, announced today that it is sponsoring a Phase II clinical study exploring a multi-pronged treatment approach to high risk and advanced-stage melanoma -- an often fatal form of cancer for which there are limited treatment options. Patients are being enrolled in the United States and Canada. The trial, called MEL11, will investigate the safety and efficacy of a therapeutic cancer vaccine regimen aimed at stimulating the body's immune system to fight melanoma.

"The MEL11 study uses an entirely new treatment approach to advanced-stage melanoma," said Teresa Petrella, MD, Medical Oncologist and Clinical Researcher at the Odette Cancer Centre at the Sunnybrook Health Sciences Centre in Toronto and the lead investigator of the trial. "The study protocol combines the use of a vaccine with more traditional anti-cancer agents to bolster the effectiveness of the immune system. Melanoma is an increasing concern in the cancer community; its incidence is on the rise and there are very few available treatment options."

The vaccine candidate is uniquely designed to stimulate the body's own defenses -- the immune system -- to find and fight cancer cells. It makes use of a modified canarypox virus, ALVAC(2), which has been shown in an extensive body of research to promote immune responses in humans. The ALVAC(2) virus contains the genes for five antigens -- molecules that induce an immune response -- that are commonly found in melanoma tumors. These antigens stimulate T-cells within the immune system to hone in on melanoma cells, and are expected to halt or slow cancer progression. The vaccine also contains the genes for three proteins called co-stimulatory molecules, which increase the immune response of T-cells to the antigens. In addition to the vaccine, patients in this trial will be treated with two other agents that augment the immune response: GM
'/>"/>

SOURCE sanofi pasteur
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  The need ... cancer treatment continuum was highlighted prominently at the ... Urological Association (AUA), in San Diego.  According to ... intensity focused ultrasound (HIFU) technology, the need for ... and for urologists to consider minimally invasive ablative ...
(Date:5/23/2013)...  Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just ... "Quite a few doctors said he had a good chance ... Gionfriddo , about her now 20-month-old son, Kaiba. "At ... would take it and run with it." They ...
(Date:5/23/2013)... May 23, 2013  Hologic, Inc. (Hologic or ... leading developer, manufacturer and supplier of premium diagnostics, ... emphasis on serving the healthcare needs of women, ... in a U.S. clinical practice comparing breast cancer ... with conventional 2D mammography alone showed a significant ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... , July 28 Intercept Pharmaceuticals, Inc., ... chronic fibrotic and metabolic diseases, today announced the signing ... the National Institute of Diabetes and Digestive and Kidney ... conduct a double blind, multi-center, study to evaluate the ...
... , WOONSOCKET, R.I. , July 27 CVS Caremark Corporation ... Wednesday, July 28, 2010 , at 9:30 a.m. (ET) with analysts ... the recently-announced strategic agreement with Aetna. , ... An audio webcast of the conference call will be broadcast simultaneously through the ...
Cached Medicine Technology:Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH) 2Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH) 3CVS Caremark Corporation to Hold Conference Call to Discuss: 2
(Date:5/24/2013)... On May 16, students, family members, and ... American University of Antigua (AUA) College of Medicine ... was the largest graduating class to date. The ceremony ... Vice President for Enrollment Management and Chief Operating Officer, ... Dean of Students and Professor and Chair – Physiology, ...
(Date:5/24/2013)... Reporter , , THURSDAY, May 23 (HealthDay News) -- Type ... with signs of serious complications seen just a few ... on the latest results, it seems like type 2 ... Chiang, senior vice president of medical affairs and community ... faster, and it appears to be at a more ...
(Date:5/24/2013)... (HealthDay News) -- Nearly three out of four ... and diarrhea, but these issues don,t significantly affect ... Researchers from Loyola University Medical Center in ... due to physiological and hormonal changes that occur ... pregnancy also can play a role. The study ...
(Date:5/24/2013)... UT (PRWEB) May 24, 2013 MonaVie announces ... America, as a new member of the Ethics Board of ... proud to have been elected to this council and will ... of the direct selling industry,” says Patrocinio. , The direct ... contributor to Brazil’s economy. The direct selling industry has, for ...
(Date:5/24/2013)... According to the new market research report “Micro Irrigation ... published by MarketsandMarkets, global micro irrigation system market expected ... year 2010 and is expected to reach $3,414.7 million ... 2011 to 2016. , Browse:, , ... , 370 pages and in-depth Table Of ...
Breaking Medicine News(10 mins):Health News:AUA Celebrates Seventh Annual Commencement Ceremony 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3Health News:Bowel Issues Affect 3 Out of 4 Pregnant Women 2Health News:MonaVie Brazil Executive Elected to Ethics Board of ABEVD 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3
... Oct. 8 Vyta Corp (OTC Bulletin Board:,VYTC) ... Nino Sorgente has,been formally engaged as an independent ... Vice President of Research and Development at,BIOAGRA, LLC, ... and Justin,Holdings, Inc. On September 15, 2008, Vyta ...
... Give an Hour, a,non-partisan, non-profit organization offering ... loved ones, announces a collaboration with,HelpPRO(R) -- a ... consumers nationwide to locate needed mental health professionals ... professionals, who join the Give,an Hour network offering ...
... cairns, funeral mounds, mummification, belief in life after death ... considered "odd" or even terrifying by another., The Greeks, ... of the ancient Issedonians chopping up their dead into ... barbeque, something entirely contrary to the Greeks, treatment of ...
... ALEXANDRIA, Va., Oct. 8 The National,Community Pharmacists ... one-term incumbent representing Georgia, for re-election to the,U.S. ... CEO of NCPA,issued the following statement:, "Senator ... and,America,s community pharmacies and the patients they serve. ...
... 8 The National,Community Pharmacists Association (NCPA) is ... Illinois, for re-election to the,U.S. Senate. Bruce Roberts, ... the following statement:, "Senator Richard Durbin is ... and the patients they serve. That is why ...
... Va., Oct. 8 The National,Community Pharmacists Association ... incumbent representing Kansas, for re-election to the,U.S. Senate. ... of NCPA,issued the following statement:, "Senator Pat ... America,s,community pharmacies and the patients they serve. That ...
Cached Medicine News:Health News:Vyta Corp Announces Engagement of Dr. Nino Sorgente as Independent Consultant 2Health News:HelpPRO and Give an Hour Join to Help Military Families Get Free Therapy Services 2Health News:Deathways open doors to unexpected cultural practices 2
The Chalam Mid Field lens can be used for air/gas exchange and has a bi-concave design to provide the widest field available in a direct image surgical lens. This lens was developed with K.V. Chalam,...
... 1.5x is specifically designed ... peeling in macular hole ... sheathotomy and macularepiretinal membrane ... and other situations warranting ...
The Flat is designed for routine vitrectomy, optic nerve neurotomy and induction of posterior vitreous detachments. It is also useful for macular hole surgery, epiretinal membranes and for removal of...
... MiniQuad ACS allows visualization of virtually ... with essentially coaxial positioning of the lens ... retinal detachment surgery, repairing giant retinal tears, ... for examining the peripheral retina in a ...
Medicine Products: